Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001214659-23-016861
Filing Date
2023-12-26
Accepted
2023-12-26 17:00:09
Documents
2
Group Members
CONCENTRA BIOSCIENCES, LLCKEVIN TANGTANG CAPITAL MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 o1226230sc13d.htm SC 13D 111599
2 GRAPHIC ktang_sig.jpg GRAPHIC 3358
  Complete submission text file 0001214659-23-016861.txt   118080
Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 858-200-3830
TANG CAPITAL PARTNERS LP (Filed by) CIK: 0001191935 (see all company filings)

EIN.: 680517277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Subject) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92480 | Film No.: 231513876
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)